Objective
Chagas'disease constitutes one of the most serious health problems of Latin America. Our aim is to characterize two antigens that may be involved on pathology and also may be good candidates for diagnostic and then to study the cellular immune response against them and their possible use in diagnostic. We plan to purify, clone and express recombinant GP 50/55 and the antigen (UA) detected in urinary specimens during T.cruzi recent infection. Autoimmunity and not direct parasite pathology is recognized as the main cause of pathogenicity. Only 15-20% of the chronic Chagasic patient will develop autoimmunity. The reasons for this are unknown. It has been proposed that different sets of autoantibodies may be produced in different patients leading to different clinical manifestations. If this is the case the detection of those antibodies may have a role in diagnosis and even prognosis of the disease. In this regard, we think it is worth to explore the relationship of autoantibodies against GP 50/55 crossreactive with human lymphocytes and the pathology in the acute and chronic phase that could eventually lead to a differential diagnostic procedure.
The production of recombinant UA antigen would allow us to obtain a monoclonal antibodies, in order to develop a new and higly sensitive method which is non invasive, in difference from the actual in use, for an early Chagas'disease diagnosis. Moreover, simpler procedures based on the monoclonal antibody could be adapted for field conditions..
Regarding to the immune response against T.cruzi T cells contribute to the eradication of the pathogen most likely by releasing lymphokines which in turn activate different parasiticidal mechanisms of phagocytes. We will try to investigate the relevance of those lymphokines and the different immune responses in the resistance against infection. Such study will help to define a pattern of protective vs pathogenic immune response. This is important before a vaccine could ever be implemented.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences basic medicine pathology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
28049 CANTO-BLANCO - MADRID
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.